This report on global infectious disease treatment market studies the increasing demand for infectious disease treatment due to rise in the drug resistant bacterial strain, early disease diagnosis and treatment and promising drug pipeline.
For the purpose of this study, the infectious disease treatment market is segmented into therapeutics (Antibacterial drugs, Antiviral drugs, Antifungal drugs, Antiparasitic drugs) and application type (AIDS, Hepatitis B, Hepatitis C, HPV, MRSA, CT/NG and Others).
The pipeline analysis for global infectious disease treatment market comprises projected market sales of Phase III anti-infective drugs estimated till 2029. We have estimated sales of very specific molecules based on the type (Imipenem/Cilastatin+relebactum, (MK-7655), S-033188, Cadazolid, Baxdela (Delafloxacin), GS-9620 (TLR-7 agonist), Doravirine (MK-1439), ZERBAXA (MK-7625A)), are the drugs in the pipeline which are anticipated to be launched during the forecast period.
The geographic segmentation of the global infectious disease treatment market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries.
North America was observed as the largest market for infectious disease treatment in the base year 2020. According to Centre for Disease Control and Prevention in 2019 about 39,513 new cases of human acquired immune deficiency syndrome (HIV). The growth is attributed mainly due to increasing prevalence of infectious disease, public awareness and early disease diagnosis and supportive reimbursement policies. Europe is expected to be the second largest market due to rising public awareness related with early disease diagnosis, improved healthcare infrastructure, government and non-government organizations arranging awareness activities and camps. Growth of Asia Pacific for infectious disease treatment market is attributed by factors like rising prevalence of infectious disease, increasing investments in drug R&D and higher disposable income in these regions. However, factors such as developing health infrastructure, increasing awareness among people about health care and tapping potential market in the remote areas to fuel the rapid growth of infectious disease treatment market in Latin America and Middle East and Africa region in the near future.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
For the purpose of this study, the infectious disease treatment market is segmented into therapeutics (Antibacterial drugs, Antiviral drugs, Antifungal drugs, Antiparasitic drugs) and application type (AIDS, Hepatitis B, Hepatitis C, HPV, MRSA, CT/NG and Others).
The pipeline analysis for global infectious disease treatment market comprises projected market sales of Phase III anti-infective drugs estimated till 2029. We have estimated sales of very specific molecules based on the type (Imipenem/Cilastatin+relebactum, (MK-7655), S-033188, Cadazolid, Baxdela (Delafloxacin), GS-9620 (TLR-7 agonist), Doravirine (MK-1439), ZERBAXA (MK-7625A)), are the drugs in the pipeline which are anticipated to be launched during the forecast period.
The geographic segmentation of the global infectious disease treatment market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries.
Therapeutics type analysis
Factors such as rising prevalence of infectious disease, technological advancement in the anti-infective drug formulation for e.g. (Ciprofloxacin Hydrochloride effervescent tablets have more gastro-retention than Ciprofloxacin Hydrochloride tablets) and rising demand for personalized medication promotes the demand for infectious disease treatment market. Antibacterial drugs holds the largest market due to increasing prevalence of bacterial infection, rise in the number of drug resistant bacterial strain will propel the demand for higher antibiotics. Antiviral drugs are anticipated to register faster growth due to high public awareness of sexually transmitted diseases such as HIV, HPV and Gonorrhea, and technological advancement in the formulation of antivirals with least side effects for e.g. (Zidovudine an antiretroviral drug is available as an IV formulation to surpass adverse effects such as nausea and vomiting in pregnant women). Overall, the global infectious disease treatment market is highly competitive with presence of multiple players like Abbott Laboratories, Johnson and Johnson, Hoffman-La Roche AG, Alere, Inc. etc. specializing in respective fields. Consolidation activities are being increasingly witnessed on the competitive front with a view to increase the technological advancement in the infectious disease treatment market.Application Analysis
Human Papillomavirus (HPV) held the largest market in the application segment, according to World Health Organization approximately 290 million (1995-2005) women suffered with HPV infection. The growth is attributed mainly due to increasing prevalence of HPV infection, high public awareness and early disease diagnosis. Hospital acquired Methicillin-resistant Staphylococcus aureus infection (MRSA) will be the fastest growing market due to the increase in number of MRSA infection in hospitals, medication lapse, unhygienic conditions in hospitals and use of non-sterilized surgical devices, and unnecessary use of antibiotics etc.North America was observed as the largest market for infectious disease treatment in the base year 2020. According to Centre for Disease Control and Prevention in 2019 about 39,513 new cases of human acquired immune deficiency syndrome (HIV). The growth is attributed mainly due to increasing prevalence of infectious disease, public awareness and early disease diagnosis and supportive reimbursement policies. Europe is expected to be the second largest market due to rising public awareness related with early disease diagnosis, improved healthcare infrastructure, government and non-government organizations arranging awareness activities and camps. Growth of Asia Pacific for infectious disease treatment market is attributed by factors like rising prevalence of infectious disease, increasing investments in drug R&D and higher disposable income in these regions. However, factors such as developing health infrastructure, increasing awareness among people about health care and tapping potential market in the remote areas to fuel the rapid growth of infectious disease treatment market in Latin America and Middle East and Africa region in the near future.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Infectious Disease Treatment market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Infectious Disease Treatment market and their expected impact during the forecast period.
Market Segmentation
Therapeutics
- Antibacterial drugs
- Antiviral drugs
- Antifungal drugs
- Antiparasitic drugs
- Projected sales of Phase III drugs estimated till 2029 (US $ Mn)
- Imipenem/Cilastatin + relebactum
- Cadazolid
- GS-9620 (TLR-7 Agonist)
- Doravirine (MK-1439)
- Others
- Tabular representation of Phase II and I drugs
Application
- Acquired Immune Deficiency Syndrome (AIDS)
- Hepatitis B
- Hepatitis C
- Human Papillomavirus
- Hospital acquired Methicillin-resistant Staphylococcus aureus infection (MRSA)
- Chlamydia trachomatis and Neisseria Gonorrhea (CT/NG)
- Others
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Infectious Disease Treatment market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Infectious Disease Treatment market?
- Which is the largest regional market for Infectious Disease Treatment market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Infectious Disease Treatment market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Infectious Disease Treatment market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Infectious Disease Treatment Market
2.2. Global Infectious Disease Treatment Market, By Therapeutics, 2021 (US$ Million)
2.3. Global Infectious Disease Treatment Market, By Application, 2021 (US$ Million)
2.4. Global Infectious Disease Treatment Market, By Geography, 2021 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2021
3. Infectious Disease Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Infectious Disease Treatment Market Vendors
3.2. Strategies Adopted by Infectious Disease Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030
4. Infectious Disease Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Infectious Disease Treatment Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Antibacterial drugs
5.3.2. Antiviral drugs
5.3.3. Antifungal drugs
5.3.4. Antiparasitic drugs
5.3.5. Projected sales of Phase III drugs estimated till 2029 (US $ Mn)
5.3.5.1. Imipenem/Cilastatin + relebactum
5.3.5.2. Cadazolid
5.3.5.3. GS-9620 (TLR-7 Agonist)
5.3.5.4. Doravirine (MK-1439)
5.3.5.5. Others
5.3.6. Tabular representation of Phase II and I drugs
6. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Acquired Immune Deficiency Syndrome (AIDS)
6.3.2. Hepatitis B
6.3.3. Hepatitis C
6.3.4. Human Papillomavirus
6.3.5. Hospital acquired Methicillin-resistant Staphylococcus aureus infection (MRSA)
6.3.6. Chlamydia trachomatis and Neisseria Gonorrhea (CT/NG)
6.3.7. Others
7. North America Infectious Disease Treatment Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
7.3. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
7.4.Infectious Disease Treatment Market: By Region, 2020-2030, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
7.4.1.1.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
7.4.1.2.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
7.4.1.3.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
8. UK and European Union Infectious Disease Treatment Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
8.3. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
8.4.Infectious Disease Treatment Market: By Region, 2020-2030, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
8.4.1.1.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
8.4.1.2.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
8.4.1.3.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
8.4.1.4.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
8.4.1.5. France
8.4.1.5.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
8.4.1.5.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
8.4.1.6.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
9. Asia Pacific Infectious Disease Treatment Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
9.3. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
9.4.Infectious Disease Treatment Market: By Region, 2020-2030, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
9.4.1.1.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
9.4.1.2.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
9.4.1.3. India
9.4.1.3.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
9.4.1.3.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
9.4.1.4.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
9.4.1.5.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
9.4.1.6.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
10. Latin America Infectious Disease Treatment Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
10.3. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
10.4.Infectious Disease Treatment Market: By Region, 2020-2030, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
10.4.1.1.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
10.4.1.2.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
10.4.1.3.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
11. Middle East and Africa Infectious Disease Treatment Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
11.3. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
11.4.Infectious Disease Treatment Market: By Region, 2020-2030, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
11.4.1.1.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
11.4.1.2.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Infectious Disease Treatment Market: By Therapeutics, 2020-2030, USD (Million)
11.4.1.3.1. Infectious Disease Treatment Market: By Application, 2020-2030, USD (Million)
12. Company Profile
12.1. Pfizer, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. F.Hoffman-La Roche AG
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Abbott Laboratories
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Abbvie, Inc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Merck & Company
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Alere, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Allergan, Inc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Bayer AG
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Baxter International Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Bristol-Myers Squibb Company
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Actelion Pharmaceuticals Ltd.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Gilead Sciences, Inc.
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
List of Figures
Figure 1 Global Infectious Disease Treatment Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Infectious Disease Treatment Market: Quality Assurance
Figure 5 Global Infectious Disease Treatment Market, By Therapeutics, 2021
Figure 6 Global Infectious Disease Treatment Market, By Application, 2021
Figure 7 Global Infectious Disease Treatment Market, By Geography, 2021
Figure 8 Market Geographical Opportunity Matrix - Global Infectious Disease Treatment Market, 2021
Figure 9 Market Positioning of Key Infectious Disease Treatment Market Players, 2021
Figure 10 Global Infectious Disease Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 11 Global Infectious Disease Treatment Market, By Therapeutics, 2021 Vs 2030, %
Figure 12 Global Infectious Disease Treatment Market, By Application, 2021 Vs 2030, %
Figure 13 U.S. Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 14 Canada Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 15 Rest of North America Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 16 UK Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 17 Germany Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 18 Spain Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 19 Italy Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 20 France Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 21 Rest of Europe Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 22 China Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 23 Japan Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 24 India Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 25 Australia Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 26 South Korea Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 27 Rest of Asia Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 28 Brazil Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 29 Mexico Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 30 Rest of Latin America Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 31 GCC Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 32 Africa Infectious Disease Treatment Market (US$ Million), 2020 - 2030
Figure 33 Rest of Middle East and Africa Infectious Disease Treatment Market (US$ Million), 2020 - 2030
List of Tables
Table 1 Global Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 2 Global Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 3 Global Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 4 North America Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 5 North America Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 6 North America Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 7 U.S. Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 8 U.S. Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 9 U.S. Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 10 Canada Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 11 Canada Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 12 Canada Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 13 Rest of North America Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 14 Rest of North America Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 15 Rest of North America Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 16 UK and European Union Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 17 UK and European Union Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 18 UK and European Union Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 19 UK Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 20 UK Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 21 UK Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 22 Germany Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 23 Germany Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 24 Germany Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 25 Spain Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 26 Spain Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 27 Spain Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 28 Italy Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 29 Italy Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 30 Italy Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 31 France Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 32 France Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 33 France Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 34 Rest of Europe Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 35 Rest of Europe Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 36 Rest of Europe Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 37 Asia Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 38 Asia Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 39 Asia Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 40 China Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 41 China Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 42 China Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 43 Japan Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 44 Japan Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 45 Japan Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 46 India Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 47 India Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 48 India Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 49 Australia Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 50 Australia Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 51 Australia Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 52 South Korea Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 53 South Korea Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 54 South Korea Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 55 Latin America Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 56 Latin America Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 57 Latin America Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 58 Brazil Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 59 Brazil Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 60 Brazil Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 61 Mexico Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 62 Mexico Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 63 Mexico Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 64 Rest of Latin America Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 65 Rest of Latin America Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 66 Rest of Latin America Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 67 Middle East and Africa Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 68 Middle East and Africa Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 69 Middle East and Africa Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 70 GCC Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 71 GCC Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 72 GCC Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 73 Africa Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 74 Africa Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 75 Africa Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Table 76 Rest of Middle East and Africa Infectious Disease Treatment Market By Therapeutics, 2020-2030, USD (Million)
Table 77 Rest of Middle East and Africa Infectious Disease Treatment Market By Projected sales of Phase III drugs estimated till 2029 (US $ Mn), 2020-2030, USD (Million)
Table 78 Rest of Middle East and Africa Infectious Disease Treatment Market By Application, 2020-2030, USD (Million)
Companies Mentioned
- Abbott Laboratories
- Johnson and Johnson
- Hoffman-La Roche AG
- Alere Inc.
